Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells

Experimental Hematology

Volumn 27, Issue 9, 1999, Pages 1375-1383

  Yotnda, Patricia ^a   Mintz, Pierre ^b   Grigoriadou, Kalliopi ^a   Lemonnier, Francois ^a   Vilmer, Etienne ^c   Langlade Demoyen, Pierre ^a  

^a INSTITUT PASTEUR   (France)

^b Ctr Integre Rech Biocliniques S   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Acute lymphoblastic leukemia; Anergy; Apoptosis; Cytotoxic T lymphocyte; Th1 Th2

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FAS ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPHENOTYPING; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD80; APOPTOSIS; BONE MARROW; CALCIUM SIGNALING; CD40 LIGAND; CELL CYCLE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MALE; MEMBRANE GLYCOPROTEINS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS;

EID: 0032823009     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00083-1     Document Type: Article

References (42)

1. Harding F.A., Arthur J.G.M., Gross J.A., Raulet D.H., JP A. CD28-mediated signalling co-stimulates murine T-cells and prevents induction of anergy in T-cell clones. Nature. 356:1992;607.
2. Gimmi C.D., Freeman G.J., Gribben J.G., Gray G., Nadler L.M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A. 90:1993;6586.
3. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D., Gray G.S., Gribben J.G., Nadler L.M. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523.
4. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways. application to autoimmune disease therapy Cell. 80:1995;707.
5. Chen L., Linsley P.S., Hellstrom K.E. Costimulation of T cells for tumor immunity. Immunol Today. 14:1993;483.
6. Boon T., De Plaen E., Lurquin C., Van den Eynde B., van der Bruggen P., Traversari C., Amar-Costesec A., Van Pel A. Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surv. 13:1992;23-37.
7. Zhang X.L., Komada Y., Zhou Y.W., Chen T.X., Sakai H., Azuma E., Ido M., Sakurai M. Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia. Cancer Immunol Immunother. 44:1997;41.
8. Prieto A., Garcia-Suearez J., Reyes E., Lapena P., Hernandez M., Alarez-Mon M. Inhibition of interleukin-2 receptor (CD25) expression induced on T cells from children with acute lymphoblastic leukemia. Exp Hematol. 21:1993;1563.
9. Zang X.-L., Komada Y., Zhou Y.W., Chen T.-X., Sakai H., Azuma E., Ido M., Sakurai M. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signal. Cancer Immunol Immunother. 4:1997;41.
10. Karawajew L., Wuchter C., Ruppert V., Drexler H., Gruss H.J., Dorken B., Ludwig W.D. Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells. Leukemia. 11:1997;1245.
11. Yotnda P., Garcia F., Peuchmaur M., Granchamps B., Duval M., Lemonnier F., Vilmer E., Langlade-Demoyen P. Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia. J Clin Invest. 101:1998;2290.
12. Ranheim E.A., Kipps T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 177:1993;925.
13. Roy M., Aruffo A., Ledbetter J., Linsley P., Kehry M., Noelle R. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol. 25:1995;596.
14. Bowen F., Haluskey J., Quill H. Altered CD40 ligand induction in tolerant T lymphocytes. Eur J Immunol. 25:1995;2830.
15. Clerici M., Sarin A., Coffman R.L., Wynn T.A., Blatt S.P., Hendrix C.W., Wolf S.F., Shearer G.M., Henkart P.A. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A. 91:1994;11811.
16. Groux H., Bigler M., de Vries J.E., Roncarolo M.G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells [see comments]. J Exp Med. 184:1996;19.
17. Sad S., Mosmann T.R. Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells. loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines J Exp Med. 182:1995;150.
18. Estaquier J., Idziorek T., Zou W., Emilie D., Farber C.M., Bourez J.M., Ameisen J.C. T helper type 1/T helper type 2 cytokines and T cell death. preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons J Exp Med. 182:1995;1759.
19. Becker J.C., Czerny C., Brocker E.B. Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol. 6:1994;1605.
20. LaSalle J.M., Hafler D.A. T cell anergy. FASEB J. 8:1994;601.
21. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109.
22. McArthur J.G., Raulet D.H. CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med. 178:1993;1645.
23. Chapman A., Stewart S.J., Nepom G.T., Green W.F., Crowe D., Thomas J.W., Miller G.G. CD11b+CD28-CD4+ human T cells. activation requirements and association with HLA-DR alleles J Immunol. 157:1996;4771.
24. Darrow T.L., Abdel-Wahab Z., Quinn-Allen M.A., Seigler H.F. Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2. Cell Immunol. 172:1996;52.
25. Hammond S.A., Bollinger R.C., Stanhope P.E., Quinn T.C., Schwartz D., Clements M.L., Siliciano R.F. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J Exp Med. 176:1992;1531.
26. Celis E., Ou D., Otvos L. Jr. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol. 140:1988;1808.
27. Nakao M., Sata M., Saitsu H., Yutani S., Kawamoto M., Kojiro M., Itoh K. CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma. Cellular Immunol. 177:1997;176.
28. Miyazaki A., Sato N., Takahashi S., Sasaki A., Kohama G., Yamaguchi A., Yagihashi A., Kikuchi K. Cytotoxicity of histocompatibility leukocyte antigen-DR8-restricted CD4 killer T cells against human autologous squamous cell carcinoma. Jpn J Cancer Res. 88:1997;191.
29. Zajac A.J., Quinn D.G., Cohen P.L., Frelinger J.A. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection. Proc Natl Acad Sci U S A. 93:1996;14730.
30. Hahn S., Gehri R., Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev. 146:1995;57.
31. Heike M., Schlaak J., Schulze-Bergkamen H., Heyl S., Herr W., Schmitt U., Schneider P.M., Meyer zum Buschenfelde K.H. Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma. evidence for several recognized antigens J Immunol. 156:1996;2205.
32. Schattner E.J., Mascarenhas J., Bishop J., Yoo D.H., Chadburn A., Crow M.K., Friedman S.M. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood. 88:1996;1375.
33. Robertson M.J., Manley T.J., Pichert G., Cameron C., Cochran K.J., Levine H., Ritz J. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma. 17:1995;51.
34. Munker R., Lubbert M., Yonehara S., Tuchnitz A., Mertelsmann R., Wilmanns W. Expression of the Fas antigen on primary human leukemia cells. Ann Hematol. 70:1995;15.
35. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449.
36. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F., Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J Exp Med. 178:1993;2231.
37. Boussiotis V.A., Barber D.L., Lee B.J., Gribben J.G., Freeman G.J., Nadler L.M. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J Exp Med. 184:1996;365.
38. Lunberg A., Gribben J., Lazo S., Nadler L. Expression and induction of B7 on leukemic cells isolated from patients with hematologic malignancies. Blood. 82:1993;123a.
39. Chen L., Ashe S., Brady W.A., Hellstrom I., Hellstrom K.E., Ledbetter J.A., McGowan P., Linsley P.S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1992;1093.
40. Matulonis U., Dosiou C., Freeman G., Lamont C., Mauch P., Nadler L.M., Griffin J.D. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B. 7-1(and B7-2 are functionally distinct. J Immunol 156):1996;1126.
41. Mauri D., Wyss-Coray T., Gallati H., Pichler W.J. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD. 80-CD28(adhesion molecules. J Immunol 155):1995;118.
42. Umetsu D.T., Esserman L., Donlon T.A., DeKruyff R.H., Levy R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol. 144:1990;2550.